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Non-typeable Haemophilus influenzae (NTHi) causes persistent respiratory infections
in patients with chronic obstructive pulmonary disease (COPD), probably linked to its
capacity to invade and reside within pneumocytes. In the alveolar fluid, NTHi is in
contact with pulmonary surfactant, a lipoprotein complex that protects the lung against
alveolar collapse and constitutes the front line of defense against inhaled pathogens and
toxins. Decreased levels of surfactant phospholipids have been reported in smokers and
patients with COPD. The objective of this study was to investigate the effect of surfactant
phospholipids on the host-pathogen interaction between NTHi and pneumocytes. For
this purpose, we used two types of surfactant lipid vesicles present in the alveolar
fluid: (i) multilamellar vesicles (MLVs, > 1µm diameter), which constitute the tensioactive
material of surfactant, and (ii) small unilamellar vesicles (SUVs, 0.1µm diameter), which
are generated after inspiration/expiration cycles, and are endocytosed by pneumocytes
for their degradation and/or recycling. Results indicated that extracellular pulmonary
surfactant binds to NTHi, preventing NTHi self-aggregation and inhibiting adhesion
of NTHi to pneumocytes and, consequently, inhibiting NTHi invasion. In contrast,
endocytosed surfactant lipids, mainly via the scavenger receptor SR-BI, did not affect
NTHi adhesion but inhibited NTHi invasion by blocking bacterial uptake in pneumocytes.
This blockade was made possible by inhibiting Akt phosphorylation and Rac1 GTPase
activation, which are signaling pathways involved in NTHi internalization. Administration
of the hydrophobic fraction of lung surfactant in vivo accelerated bacterial clearance
in a mouse model of NTHi pulmonary infection, supporting the notion that the lipid
component of lung surfactant protects against NTHi infection. These results suggest
that alterations in surfactant lipid levels in COPD patients may increase susceptibility to
infection by this pathogen.
Keywords: nontypeable Haemophilus influenzae, pulmonary surfactant, phospholipids, alveolar epithelial cells,
host-pathogen interaction, bacterial invasion, RAC-1, PI3K/Akt
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INTRODUCTION
Non-typeable Haemophilus influenzae (NTHi) is a non-
capsulated Gram-negative bacterium that has been recognized
as a major causative pathogen of mucosal infections such
as otitis media in children and exacerbations of chronic
obstructive pulmonary disease (COPD) in adults (1–5). NTHi
is a common commensal of the human nasopharynx that
induces a polymicrobial disease, typically due to concurrent
or predisposing respiratory viral infection (3). In the upper
respiratory tract, the main pathological condition caused by
NTHi is acute otitis media, with almost 60% of the cases
attributable to this bacterium (1). In the lower airways, NTHi
infections are highly prevalent in individuals suffering from
COPD, bronchiectasis, cystic fibrosis, and pneumonia (1, 2).
In particular, NTHi is a very common bacterial colonizer in
the airways of COPD patients, and is the most frequently
isolated bacterium in exacerbations of COPD, contributing to
inflammation and disease progression (2, 5).
One of the mechanisms likely to be involved in the persistence
of respiratory infections by NTHi is its capacity to invade
airway epithelial cells (2, 5–7). Intracellular NTHi has been
detected in epithelial cells from bronchial biopsies of patients
suffering chronic bronchitis (8) and COPD (9). Intracellular
invasion of lung epithelial cells enables NTHi to escape from
the host immune system and to reside inside cells with high
access to essential nutrients (10). Moreover, intracellular NTHi
is protected from high concentrations of antibiotics, hampering
clinical treatment (11). Therefore, we put forward the notion that
preventing NTHi from invading lung epithelial cells is crucially
important for the prophylaxis and treatment of respiratory
NTHi infections.
To penetrate into airway epithelial cells, adherence of NTHi
to such cells is essential, and several adhesion molecules on
NTHi have been identified (12–15). They can bind either
integrin receptors on the epithelial cell surface (6) or extracellular
matrix proteins that interact with the epithelium (13, 15). In
healthy individuals, the alveolar epithelium is exceptionally well-
defended from bacterial infection through multiple mechanisms
of bacterial clearance, including expression of antimicrobial
peptides, lung collectins (SP-A and SP-D), and active surveillance
of airway macrophages (16–18). In this study, we wondered
whether the complicated network of extracellular membranes,
called pulmonary surfactant, could also protect the host from
NTHi adhesion and invasion.
Pulmonary surfactant is a complex lipoprotein
system, exquisitely conserved across species. Surfactant
is composed of 90 wt % lipids and 10 wt % proteins.
Phospholipids are the major lipid component of surfactant,
especially dipalmitoylphosphatidylcholine (DPPC) (19, 20).
Phosphatidylglycerol (PG) represents a major unsaturated
anionic component (19, 20). Four surfactant proteins form
part of this material: the hydrophobic proteins SP-B and SP-C,
which are inserted in surfactant membranes and are essential
for surfactant biophysical function, and the soluble collectins
SP-A and SP-D, which are involved in innate immune host
defense (18–24). Lung surfactant is synthesized and secreted
by type II pneumocytes. After secretion to the alveolar space,
SP-B/SP-C and phospholipids form a multilayered surface film
at the air-liquid interface that decreases alveolar surface tension
on expiration, and thus prevents lung collapse and respiratory
failure (19, 20). Airway instillation of surfactant is in general
use for treatment of respiratory distress syndrome in preterm
babies (25, 26). Replacement surfactants consist of lipid extract
preparations obtained from animal bronchoalveolar fluids,
containing phospholipids, mainly DPPC, and the hydrophobic
proteins SP-B and SP-C (26). Interestingly, replacement
surfactants also improve recovery of animal models of otitis
media (27, 28). Lipoprotein structures similar to lung surfactant
seems to be present in other mucosal surfaces exposed to
the external environment, suggesting the importance of these
lipoprotein structures.
In healthy individuals, the amount of surfactant phospholipids
(particularly saturated phosphatidylcholine) is tightly regulated
and does not significantly change through life (29). However,
in pathological conditions, such as COPD, pulmonary fibrosis,
or pneumonia, the concentration of surfactant phospholipids
decreases (30–33). Whether the decrease of surfactant lipids
increases susceptibility to infection by inhaled pathogens in these
respiratory diseases remains mostly unaddressed.
In the present study, we tested the hypothesis that surfactant
lipids may protect against NTHi infection in the lung. We
found that extracellular large surfactant aggregates bind to
NTHi and act as a physical barrier that inhibits adhesion
of NTHi to pneumocytes and, consequently, invasion. In
addition, endocytosed small lipid vesicles interfere with
cytoskeletal reorganization required for bacterial entry in
pneumocytes, inhibiting NTHi invasion. The protective effect of
the hydrophobic fraction of pulmonary surfactant was assessed
in a mouse model of NTHi infection.
MATERIALS AND METHODS
Isolation of Lung Surfactant and
Preparation of the Surfactant Hydrophobic
Fraction
Pulmonary surfactant was obtained from bronchoalveolar
lavages (BAL) of male Sprague Dawley rats (Envigo). Rats
(∼350 g) were euthanized with carbon dioxide and the
cardiopulmonary block was extracted to perform BALs with
40ml of PBS (0.2mM EDTA). The isolation of lung surfactant
experiment was reviewed and approved by the local ethics
committee (both Complutense University of Madrid and
Autonomous Community of Madrid), according to Directive
2010/63/EU of the European Parliament and the Spanish law
RD53/2013 on protection of animals used for experimentation.
The mouse lung infection assays were conducted with the
approval of Animal Experimentation Committee from the
Universidad Pública de Navarra and the authorization of the local
government, under the same regulation as above, and following
the FELASA and ARRIVE guidelines.
Large surfactant aggregates (heavy subtype surfactant) were
obtained as previously described (34, 35). Briefly, BAL was
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centrifuged at 100,000 g for 1 h at 4◦C to obtain large surfactant
aggregates in the resulting pellet, which largely contains
surfactant lipids and the apolipoproteins SP-A, SP-B, and SP-
C. In contrast, about 80% of the total SP-D from BAL does
not sediment and remains in the supernatant. The hydrophobic
fraction of lung surfactant (composed of surfactant lipids, SP-
B, and SP-C) was obtained by chloroform/methanol extraction
as previously reported (34, 35). The organic solvent was then
evaporated to dryness under a stream of nitrogen, and traces of
solvent were subsequently removed by evacuation under reduced
pressure overnight. Total phospholipid was determined from
aliquots of the surfactant hydrophobic fraction by phosphorus
analysis (36).
Multilamellar vesicles (MLVs) of the surfactant hydrophobic
fraction were prepared by hydrating the dry proteolipid film in
10mM phosphate buffered saline (138mM NaCl, 2.7mM KCl),
pH 7.4, (PBS) and allowing them to swell for 1 h at 55◦ C.
After vortexing, the resulting multilamellar vesicles were used
for in vitro and in vivo assays. This surfactant preparation
was used to test the effect of surfactant in a mouse model of
NTHi infection.
Surfactant Lipid Vesicles Preparation
Experiments were done using a synthetic mixture of surfactant
phospholipids (PL), in the form of either MLVs or small
unilamellar vesicles (SUVs). Surfactant vesicles were composed
of dipalmitoylphosphatidylcholine (DPPC), 1-palmitoyl-2-
oleoyl-phosphatidylglycerol (POPG), and palmitic acid (PA)
(Avanti Polar Lipids) at weight ratios of 23:10:1.6 as previously
reported (37–39). The lipid composition of these vesicles
was chosen according to the following criteria: (i) a high
DPPC content, which is the main phospholipid constituent of
pulmonary surfactant (∼50 wt.% of the total surfactant PL); (ii)
the presence of an unsaturated anionic phospholipid (POPG),
which forms part of lung surfactant (∼8–15 wt.%); and (iii) the
presence of small amounts of palmitic acid in surfactant (19, 20).
Preparation of MLVs and SUVs from surfactant lipids was
carried out as described in Sáenz et al. (37, 38), and Cañadas
et al. (40). The required amounts of DPPC, POPG, and PA were
dissolved in chloroform/methanol (2:1 v/v). The solvent was then
evaporated to dryness under a gentle stream of nitrogen. Traces
of solvent were subsequently removed in a vacuum centrifuge
for 2 h. In cases where the lipofilic fluorescent tracer 1,1′-
Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate
[DiIC18(3)] (Thermofisher Scientific) was incorporated in the
lipid mixture, the lipofilic probe was dissolved in methanol and
added to the lipid mixture at a DiIC18/surfactant phospholipid
molar ratio of 1:200, before solvent removal. MLVs were
prepared by hydrating the dry lipid film with PBS, allowing them
to swell for 1 h at 45◦C, a temperature above the gel to liquid
phase transition temperature (Tm) of these membranes (37, 38).
To prepare SUVs, the resulting MLVs were sonicated at the same
temperature (45◦C) during 8min at 390 W/cm2 (burst of 0.6 s,
with 0.4 s between bursts) in a UP 200S sonifier with a 2mm
microtip (Hielscher Ultrasonics).
The size of lipid vesicles was measured at 25◦C in a
Zetasizer Nano S (Malvern Instruments, Malvern, UK) equipped
with a 633-nm HeNe laser, as previously reported (18, 22).
Three scans were performed for each sample. Zeta potential
measurements were performed with a Zetasizer Nano S (Malvern
Instruments), applying an electric field across the dispersion.
Measurements were performed in PBS in the presence and
absence of 0.4 mM Ca2+.
Bacterial Strains, Media, and Growth
Conditions
The two NTHi strains used in this study are clinical isolates from
patients with otitis media (NTHi375) (6) and COPD (NTHi398)
(14). Frozen stocks of NTHi strains were thawed and then
grown on chocolate agar plates (bioMérieux) or on brain heart
infusion broth (BHI) supplemented with haemin 10µg/ml and
β-NAD 10µg/ml (Sigma-Aldrich) (sBHI). Bacteria were grown
overnight at 37◦C in a humidified 5% CO2 atmosphere.
Epithelial Cell Cultures and Bacterial
Infection
Experiments were performed using the mouse lung epithelial
cell line MLE-12 (ATTC R© CRL-2110TM, Manassas, VA, USA)
and the human alveolar basal epithelial cell line A549
(ATTC R© CCL-185TM). Cells were maintained in RPMI 1640
supplemented with 10% (v/v) heat-inactivated fetal bovine
serum (FBS), antibiotics (100 U/ml penicillin and 100µg/ml
streptomycin), and 2mM L-glutamine (BioWhittacker). Lung
epithelial cells were incubated at 37◦C in a humidified 5%
CO2 atmosphere.
Bacterial adhesion and invasion assays were performed as
described previously (6, 7) in the presence and absence of
surfactant phospholipid vesicles (MLVs or SUVs). MLE-12 or
A549 cells were seeded to a density of 50,000 cells per well
in 24-well tissue culture plates for 24 h. Cells were grown in
complete medium with 5% FBS [RPMI 1640 tissue culture
medium supplemented with antibiotics (100 U/ml penicillin and
100µg/ml streptomycin), 2mM L-glutamine, and 5% FBS]. A
confluence of 90% was reached at the time of the bacterial
infection. The following day, cells were incubated with NTHi
in the presence or absence of MLVs. For SUVs, cells were (i)
pre-incubated with SUVs during 24 h to allow PL endocytosis
before NTHi infection, (ii) co-incubated with SUVs at the onset
of NTHi infection, or (iii) post-incubated with SUVs after
NTHi infection.
For NTHi infection, bacteria were recovered with 1ml
PBS from a chocolate agar plate grown overnight. Bacterial
suspensions were adjusted to OD600 = 1, ∼10
9 colony forming
units (C.F.U.)/ml. Cells were infected with 50 µl (108 C.F.U./ml)
of the adjusted bacterial suspension in 1ml of Hank’s balanced
buffered saline (HBBS) (137mM NaCl, 5.4mM KCl, 0.25mM
Na2HPO4, 0.44mM KH2PO4, 1.3mM CaCl2, 1mM MgSO4,
4.2 mM NaHCO3).
For adhesion experiments, cells were infected for 30min,
washed three times with PBS, and lysed with 300 µl of 0.025%
(w/v) saponin in PBS for 10min at room temperature.
The resulting lysates were diluted serially 1/10 in PBS,
and serial dilutions were plated on sBHI agar (6, 7).
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Colonies were counted and the results were expressed as
the percentage (%) of C.F.U. related to the control (not incubated
with lipids).
For invasion assays, cells were infected for 2 h and washed
three times with PBS. Cells were then incubated for an additional
1 h with RPMI 1640 containing 10% FBS and 200µg/ml
gentamicin to kill extracellular bacteria. Then, cells were washed
three times with PBS and lysed as described above. Serial
dilutions were plated on sBHI agar (6, 7). Colonies were counted
and the results were expressed as % C.F.U. related to the control
(not incubated with lipids).
In some experiments, cells were pre-incubated in the presence
of anti-SR-BI blocking antibody for 30min. Rabbit IgG anti-
SR-BI [NB400-113 (Novus, Biologicals)] or its corresponding
normal Rabbit IgG control (R&D Systems) were used at a
working concentration of 1:100 in culture medium. Then, SUVs
(250µg/ml) were added to the medium for an additional
2 h. Afterwards, the NTHi infection assay was carried out as
described above.
Bacterial Killing Assay
NTHi strains were grown on chocolate agar. Bacteria were
harvested in PBS, NaCl 100mM, 1% (w/v) trypticasein soy
broth to a final concentration of 108 C.F.U./ml. Then, 100
µl of bacterial suspension (107 C.F.U.) were incubated with
either 250µg/ml of PL (present as MLVs) or 20µg/ml of
polymyxin B (PMB) for 2 h at 37◦C in a humidified 5%
CO2 atmosphere. Bacteria were then stained with 5µM 5-
(and-6)-carboxyfluorescein diacetate, succinimidyl ester (CFSE)
(ThermoFisher Scientific), which stains active and inactive
bacteria (41). Bacteria were centrifuged, washed with PBS,
and resuspended in 100 µl PBS with 7.5µM propidium
iodide, to stain dead bacteria. Bacteria were incubated for
5min at 37◦C in a humidified 5% CO2 atmosphere, and
then centrifuged, resuspended in 10 µl PBS, and placed on
a microscope slide to be immediately analyzed. Micrographs
were taken with a 40x objective in a fluorescence microscope
Nikon ECLIPSE TE2000-U. Dead and live bacteria were counted
in six micrographs of each experimental condition using
Image J software. Data are shown as % of dead bacteria to
total bacteria.
Bacterial Aggregation Assay
Otitis NTHi was grown on chocolate agar for 16 h and diluted
in HBSS without CaCl2 to OD600 = 1. Bacterial aggregation
was assessed by measuring changes in light absorbance at
600 nm during 3 h without shaking, in a spectrophotometer
DU-800 (Beckman Coulter, Fullerton, USA). Readings were
taken every 3min. Aggregation is observed as a decrease in
absorbance as bacterial aggregates precipitate out of solution.
To test the effect of surfactant phospholipids (MLVs or SUVs)
on this process, a suspension of NTHi was carefully mixed
with and without surfactant lipids (MLVs or SUVs) at room
temperature, and bacterial aggregation was measured. Control
experiments with phospholipid vesicles alone, without bacteria,
were performed.
Confocal Microscopy
Endocytosis of lipid vesicles (either MLVs or SUVs) were
analyzed by confocal microscopy. Cells were seeded to a density
of 50,000 cells per well in 24-well tissue culture plates for
24 h. Each well-contained a plastic coverslip previously sterilized
under UV light for 10min. Cells were grown in complete
medium with 5% FBS. The following day, cells were incubated
for 5, 10, 30min, 1, 4, or 24 h with MLVs or SUVs (250 µg
PL/ml), fluorescently labeled with DiIC18(3) (λexc = 549 nm;
λem = 565 nm).
To determine whether the internalization of PL was
mediated by the scavenger receptors SR-BI or CD36, confocal
microscopy experiments were performed in the presence of
either blocking antibodies [mouse IgAκ anti-CD36 (Abcam) and
rabbit IgG anti-SR-BI] or their isotype controls [mouse IgAκ
isotype control (Abcam) and normal rabbit IgG control], at a
working concentration of 1:100, for 30min. Then, cells were
incubated for 1 h with lipid vesicles (250 µg PL/ml) stained
with DiIC18(3).
After incubation with vesicles, cells were washed three
times with PBS and fixed with 4% paraformaldehyde
(PFA) in PBS for 30min at room temperature. Staining
of plasma membrane and organelles was performed with
5µg/ml wheat germ agglutinin (WGA) conjugated with
Alexa Fluor 488 for 10min at room temperature. Nuclei
were stained with 1µg/ml 4′, 6-diamino-2-phenylindol
(DAPI) for 5min. Coverslips were mounted onto glass
slides using ProLong Diamond (Thermo Fisher Scientific),
and micrographs were taken under an Olympus FV1200
confocal system.
NTHi invasion of alveolar epithelial cells was also analyzed
by confocal microscopy as in Morey et al. (6) and López-Gómez
TABLE 1 | The average size distribution and zeta potential of MLVs and SUVs
used in this study, determined in PBS in the absence and presence of
physiological concentrations Ca2+.
Vesicle type Composition [Ca2+]
(mM)
Z-average
(nm)
Z-potential
(mV)
MLVs PL/SP-B/SP-C (Native
surfactant)
0.0 2,651 ± 45 −43.8 ± 0.1
0.4 2,380 ± 28 −30.4 ± 0.3
Downsizing MLVs
(sonication) (a)
PL/SP-B/SP-C (Native
surfactant)
0.0 283 ± 2 −39.0 ± 0.2
0.4 648 ± 15 −24.0 ± 0.2
MLVs DPPC/POPC/PA
(Surfactant lipid
mixture)
0.0 1,057 ± 17 −39.5 ± 0.6
0.4 3,100 ± 27 −27.5 ± 0.3
Downsizing MLVs
(sonication) (b)
SUVs
DPPC/POPC/PA
(Surfactant lipid
mixture)
0.0 98 ± 5 −36.0 ± 0.3
0.4 110 ± 8 −26.0 ± 0.4
Phospholipid (PL) concentration: 0.25 mg/mL.
(a)Small vesicles from the hydrophobic fraction of native surfactant were not used in this
study due to their instability and rapid aggregation induced by the presence of surfactant
hydrophobic proteins SP-B and SP-C. They aggregated in the presence of calcium and
tend to rapidly aggregate over time.
(b)This sample showed a polydispersed size-distribution, with two major peaks centered
at 60 ±7 nm and 31 ± 2 nm, and a minor peak at 677 ± 5. The average size is ≤
100 nm (SUVs).
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et al. (7). Once invasion experiments were performed and cells
were treated with gentamicin, as described above, cells were
washed three times with PBS and fixed with 4% PFA in PBS for
30min at room temperature. Then cells were permeabilized with
0.1% saponin in PBS, and staining was performed in 10% FBS and
0.1% saponin in PBS. NTHi was stained with rabbit anti-NTHi
antibody at a working concentration of 1:800 (6), followed by
a secondary antibody conjugated with Alexa Fluor 488 (1:100).
Late endosomes were stained with anti-LAMP-1 antibody
conjugated with phycoerythrin at a working concentration of
1:300 (eBioscience). Nuclei were stained with 1µg/ml DAPI for
5min. Coverslips were mounted onto glass slides using ProLong
Diamond, and images were taken with an Olympus FV1200
confocal system. Quantification of internalized NTHi bacteria
(colocalized with late endosomes) per cell number was performed
using Image J software on each of 12 micrographs per treatment
and experiment.
Flow Cytometry
Alveolar epithelial cells were seeded to a density of 80,000
cells per well in 24-well tissue culture plates and were grown
overnight in complete medium with 5% FBS. For analysis of
endocytosis of SUVs, cells were incubated for 30min with
or without either blocking antibodies for scavenger receptors
FIGURE 1 | Small vesicles, but not multilamellar vesicles, of pulmonary surfactant are internalized by pneumocytes. (A) MLE-12 pneumocytes were incubated with
DiIC18(3)-labeled SUVs composed of a mixture of surfactant lipids (250 µg PL/ml) for 10min, 1, 4, or 24 h. Cells were fixed and stained with Alexa Fluor
488-conjugated WGA. Nuclei were stained with DAPI. Endocytosis of lipid vesicles was analyzed by confocal microscopy. (B) As in (A), but cells were incubated with
DiIC18(3)-labeled MLVs (250 µg PL/ml) for 4 and 24 h. (C) Cells were incubated with DiIC18(3)-labeled SUVs for the indicated times and analyzed by flow cytometry.
ANOVA followed by Bonferroni multiple comparison test was used. *p < 0.05 and ***p < 0.001 when compared to control cells in the absence of lipids. Trypan blue
(TB) was used to quench extracellular vesicles attached to the cell membrane after 24 h incubation. (D) Hydrodynamic diameter of surfactant vesicles (SUVs and
MLVs) determined by dynamic light scattering. The y-axis represents the relative intensity of the scattered light; the x-axis denotes the hydrodynamic diameter of the
particles present in the solution. One representative experiment of three is shown.
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(mouse IgAκ anti-CD36 and rabbit IgG anti-SR-BI) or their
appropriate isotype controls, all used at a working concentration
of 1:100 in medium. Then, SUVs fluorescently labeled with
DiIC18(3) were added to the cells at a concentration of
100 µg PL/ml, and cells were incubated with lipid vesicles
for the indicated times. Next, cells were trypsinized and
collected in tubes for centrifugation. After two washes with
PBS, cells were resuspended in 200 µl PBS and analyzed by
flow cytometry using Becton-Dickinson FACSCan and Cell
Quest software.
FIGURE 2 | Extracellular multilamellar vesicles of pulmonary surfactant inhibit adhesion of NTHi to pneumocytes and decrease NTHi self-aggregation. (A) MLE-12
cells were infected with NTHi clinical strains from patients with otitis media and COPD, in the presence or absence of MLVs (100 or 250 µg PL/ml) prepared from
either the hydrophobic fraction of native surfactant (PL/SP-B/SP-C) or a mixture of surfactant lipids (PL). For adhesion experiments, cells were infected for 30min,
washed, and lysed. For invasion assays, cells were infected for 2 h, washed, and incubated for an additional 1 h with gentamicin to kill extracellular bacteria. The
resulting lysates were plated on sBHI agar. Colonies were counted and the results were expressed as percentages of C.F.U. relative to infected cells in the absence of
lipids. Results are mean ± SEM of three independent experiments run in triplicate. ANOVA followed by Bonferroni multiple comparison test was used. *p < 0.05, **p
< 0.01, and ***p < 0.001 when compared with NTHi-infected pneumocytes in the absence of lipids. (B) NTHi (otitis strain) were incubated in the presence or absence
of MLVs (250µg/ml) composed of either a mixture of surfactant lipids (PL), or the hydrophobic fraction of native surfactant (PL/SP-B/C) for 30min. Bacteria were then
stained with carboxyfluorescein diacetate succinimidyl ester (green), and bacterial viability was assessed by propidium iodide exclusion. Polymixin B (PMB) (20µg/ml)
was used as a positive control of bacterial killing. Data were expressed as % of dead bacteria. Results are mean ± SEM. ANOVA followed by the Bonferroni
multiple-comparison test was used. ***p < 0.001 vs. untreated bacteria. (C) Effect of surfactant vesicles on NTHi self-aggregation. NTHi (otitis strain) was incubated in
the presence or absence of MLVs (250 µg PL/ml) prepared from the hydrophobic fraction of native surfactant. Bacterial aggregation was monitored by measuring the
decrease of absorbance at 600 nm every 3min. Four independent experiments were performed. Results are mean ± SEM. Student’s t-test was used. ***p < 0.001.
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To test the effect of phospholipid uptake on the expression
of SR-BI or CD36 receptors on the cell surface, cells were
incubated in the presence or absence of SUVs (250 µg PL/ml)
for 2 h. Then cells were harvested with cold PBS 10mM EDTA
and incubated with 10% FBS-supplemented medium, followed
by incubation with either anti-SR-BI, anti-CD36, or isotype
controls and appropriate secondary Alexa Fluor 488-conjugated
antibodies. Following surface staining, samples were analyzed by
flow cytometry using Becton-Dickinson FACScalibur and Cell
Quest Pro software.
Western Blot Analysis of Akt
Phosphorylation
Cells were seeded to a density of 50,000 cells per well in
24-well tissue culture plates and were grown overnight in
complete medium with 5% FBS. The following day, cells
were pre-incubated for 24 h with different concentrations
of surfactant PL (present in solution as SUVs) to allow
their endocytosis by alveolar epithelial cells. Then, cells were
infected with NTHi following the same conditions previously
explained for invasion experiments. After 45min of cell-
pathogen contact, cells were washed three times with PBS
and lysed with 120 µl lysis buffer composed of 10mM
HEPES, 1.5mM MgCl2, 10mM KCl, 0.5mM EDTA, 0.2%
Triton X-100, 1mM benzamidine, 20µg/ml aprotinin, 20µg/ml
leupeptin, 20mM β-glycerophosphate, 10mM NaF, 10mM
sodium pyrophosphate, and 2mM orthovanadate (Sigma-
Aldrich). Samples were resolved by SDS-PAGE under reducing
conditions and transferred to polyvinylidene fluoride (PVDF)
membranes (Bio-Rad). Membranes were blocked with 5 %
(w/v) skimmed milk in PBS and were incubated with the anti-
phospho-Akt (Ser473) antibody (1:5000), or Akt antibody (Cell
Signaling) (1:1000), overnight at 4◦C. After a washing step in PBS,
membranes were incubated for 1 h at room temperature with
the appropriate secondary antibody conjugated with horseradish
peroxidase (Cell Signaling). Membranes were washed in PBS
and exposed to ECL reagents (Millipore). Immunoreactive bands
were quantified using Quantity One Software (Bio-Rad). Results
are shown as p-Akt normalized to total Akt, and expressed as
% of pAkt/Akt induced by NTHi in cells in the absence of
surfactant PL. Data were presented as the p-Akt intensity of
each band normalized for the intensity of the corresponding
total Akt band (same sample) and referred as the correspondent
percentage in relation to cells infected with NTHi but not treated
with phospholipids.
Rac1-GTP Pull Down
Pull down assays were performed as described in Castillo-Lluva
et al. (42) andWoodcock et al. (43). Cells were seeded to a density
of 500,000 cells per plate in 60 cm diameter tissue culture plates
and were grown in completemediumwith 5% FBS. The following
day, SUVs (250µg PL/ml) were added to the cells for 24 h to allow
PL endocytosis. Then cells were infected with NTHi for 2 h as
described above for bacterial invasion experiments.
To measure endogenous Rac GTPase activity, cells were
lysed on ice in glutathione-S-transferase-fish buffer (50mM
TrisHCl, pH 7.5, 100mM NaCl, 2mM MgCl2, 1% (v/v) Nonidet
P-40, 10% (v/v) glycerol, and protease inhibitors [0.5mM
benzamidine, 10µg/ml aprotinin, 10µg/ml leupeptin] (Sigma-
Aldrich) containing 1.5 µg of a biotinylated p21-activated kinase
(PAK) derived CRIB (Cdc42/Rac interacting binding) peptide
per assay. Cleared cell lysates were incubated at 4◦C for 30min.
Active Rac/CRIB complexes were precipitated using streptavidin-
conjugated magnetic sepharose beads (GE Healthcare) for a
further 15min at 4◦C. Following washes in glutathione-S-
transferase-fish buffer, protein samples were retrieved with 1×
SDS-PAGE sample buffer and processed for Western blotting
with anti-Rac antibody (Becton Dickinson).
NTHi Mouse Lung Infection
CD1 R© IGS (Caesarian-derived 1 from Charles River
Laboratories, Massachusetts, U.S.A.) mice were used to establish
a model of NTHi lung infection, as previously described (44, 45).
CD1 female mice (18–20 g) aged 4–5 weeks were purchased from
Charles River Laboratories (France), housed under pathogen-
free conditions at the Institute of Agrobiotechnology facility
(registration number ES/31-2016-000002-CR-SU-US), and used
at 22–25 g. Before NTHi infection, the surfactant hydrophobic
fraction (or the same volume of PBS in the untreated group) was
intratracheally instilled into the lung at 37◦C at a dose of 25mg
PL/kg body weight (40 µl of surfactant at a PL concentration of
13.75 mg/ml). Subsequently, 10 µl of PBS (uninfected group)
or a NTHi375 suspension containing 4 × 109 C.F.U./ml (4 ×
107 C.F.U./mouse) (NTHi infected group) were intratracheally
administered. Mice were randomly divided into 6 infected (n
= 5) groups and 2 non-infected (n = 3) control groups. The
NTHi-infected groups are: (i) animals treated with surfactant,
euthanized at 6 h post-infection; (ii) treated with surfactant,
euthanized at 12 h post-infection; (iii) treated with surfactant,
euthanized at 24 h post-infection; and untreated groups instilled
with PBS, (iv) euthanized at 6 h, (v) 12 h, and (vi) 24 h post-
infection. The uninfected control groups are: (1) animals treated
with surfactant; and (2) animals instilled with PBS.
In all animals, lungs were aseptically removed and weighed.
The left lung was clamped and separated to obtain lung
homogenates in 1:10 (w/v) sterile PBS. The right lung was
lavaged five times with sterile PBS to obtain the bronchoalveolar
lavage (BAL). BAL fluid was centrifuged at 2000 × g for 10min,
and the pellet was resuspended in 1ml RPMI 10% FBS as
described previously (18). A 50-µl aliquot was stained with an
equal volume of 0.4% trypan blue (Sigma-Aldrich) for total cell
count on a hemocytometer. Differential cell counts were made
on cytospin preparations stained with May–Grünwald–Giemsa
(Sigma-Aldrich). For bacterial count in cell-free BAL and lung
homogenate, dilutions of BAL and lung homogenates were plated
in triplicate on BHI-agar plates, and the number of CFUs was
determined after an overnight incubation at 37◦C. Data were
expressed as log10 CFU± SEM/mouse.
Statistical Methods
Data are presented as means ± SEM. Differences in means
between groups were evaluated by one-way ANOVA, followed
by the Bonferroni multiple comparison test. Student’s t-test was
used when comparing two groups. An α level ≤ 5% (p ≤ 0.05)
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FIGURE 3 | Endocytosed surfactant vesicles inhibit NTHi invasion of
pneumocytes. MLE-12 pneumocytes were incubated with SUVs composed of
a mixture of surfactant lipids. Cells were either pre-incubated with SUVs for
24 h prior to infection (A), co-incubated with SUVs and NTHi (B), or
post-incubated with SUVs for 1.5 or 2.5 h after infection with NTHi (C). For
bacterial adhesion experiments, cells were infected for 30min. For invasion
assays, cells were infected for 2 h, washed, and incubated with gentamicin
(Continued)
FIGURE 3 | to kill extracellular bacteria. Cells were lysed and plated on sBHI
agar. Data are shown as percentage of C.F.U. relative to infected cells in the
absence of lipid vesicles. Results are mean ± SEM of three independent
experiments performed in triplicate. ANOVA followed by the Bonferroni
multiple-comparison test was used. **p < 0.01, and ***p < 0.001 when
compared with infected pneumocytes in the absence of lipids.
was considered significant. SigmaPlot version 11.0 was used for
statistical tests.
RESULTS
Two different surfactant subtypes are present in the alveolar fluid:
(i) a heavy subtype or large surfactant aggregates, rich in SP-B
and SP-C, that form MLVs in solution and constitute the freshly
secreted surfactant tensioactive material; and (ii) a light subtype
characterized by the presence of small vesicles devoid of SP-B
and SP-C and by poor surface activity. These small vesicles are
generated after inspiration/expiration cycles (19).
In this study, we used two types of lipid vesicles with
different sizes, composed of either the hydrophobic fraction
of surfactant (PL/SP-B/SP-C) or a mixture of surfactant lipids
(DPPC/POPG/PA). Table 1 shows the average size distribution
and zeta potential of MLVs and SUVs used in this study,
determined in PBS in the absence and presence of physiological
concentrations Ca2+. Zeta potential measurements of lipid
vesicles used in this study confirm that they are negatively
charged due to the presence of anionic phospholipids. The
Zeta potential value for lipid vesicles composed of a surfactant
lipid mixture was −39.5 ± 0.6mV, similar to that obtained for
the hydrophobic fraction of native surfactant: −43.8 ± 0.1mV
(Table 1). The presence of calcium decreased Zeta potential
values to−27.5± 0.3 and−30.4± 0.3mV, respectively.
MLVs used in this study mimic the lung surfactant
multilayers present in the hypophase of the air-liquid interface
in the alveolus, whereas SUVs resemble the small lipid
vesicles produced as a consequence of breathing compression-
expansion cycles.
Lipid Vesicle Uptake by Alveolar Epithelial
Cells Depends on Vesicle Size
Alveolar epithelial cells are always in contact with surfactant
lipid vesicles and ingest abundant amounts of this material to
maintain surfactant homeostasis. However, the process of lipid
uptake by alveolar epithelial cells and the receptors involved are
incompletely understood.
To directly assess the effect of vesicle size on lipid uptake by
alveolar epithelial cells, we incubated lung epithelial cell lines
(mouse MLE-12 and human A549 cells) stained with Alexa Fluor
488-conjugated wheat germ agglutinin and DAPI in the presence
and absence of fluorescent lipid vesicles of different sizes (MLVs
or SUVs) composed of surfactant lipids (DPPC/POPG/PA). Lipid
uptake was analyzed by confocal microscopy. We observed a
time-dependent increase in the engulfment of SUVs, but not
MLVs, by mouse MLE-12 (Figures 1A,B) and human A549
(Supplementary Figure 1) cells. Fluorescent small lipid vesicles
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were observed inside pneumocytes after 1 h of incubation, and
the greatest uptake of SUVs seems to occur at 24h (Figure 1A).
MLVs were not internalized by mouse and human pneumocytes
after 24 h (Figure 1B and Supplementary Figure 1). Flow
cytometry analysis of the time-dependent entry of fluorescent
small lipid vesicles in mouse pneumocytes indicated that
maximal cell fluorescence was observed at 24 h (Figure 1C). At
this time, no extracellular vesicles attached to the cell membrane
are quenched by trypan blue. Figure 1D show the different
hydrodynamic sizes of the vesicles (MLVs and SUVs) used in this
study, determined by dynamic light scattering.
According to these results, MLVs, which cannot be
internalized by pneumocytes, were used in this study to
determine the extracellular effect of lung surfactant on NTHi
infection in vitro, whereas SUVs, which can be internalized,
can be used to analyze the intracellular effect of endocytosed
surfactant lipids.
Extracellular Large Surfactant Aggregates
Bind to NTHi and Inhibit Bacterial Adhesion
to Pneumocytes
The analysis of the extracellular effect of surfactant lipids on the
adhesion and invasion of NTHi to pneumocytes was performed
with MLVs prepared from either the hydrophobic fraction of
native surfactant (PL/SP-B/SP-C) or a mixture of surfactant
lipids (PL). For adhesion experiments, cells were infected for
30min, washed, and lysed. For invasion assays, cells were
infected for 2 h, washed, and incubated for an additional 1 h
with gentamicin to kill extracellular bacteria (6, 7). We used
two NTHi clinical strains, isolated from patients with otitis
media and COPD. Figure 2A shows that co-incubation of mouse
MLE-12 cells with MLVs and NTHi strains results in reducing
the number of bacteria adhered and internalized in the cells.
For both NTHi strains, inhibition of bacterial adhesion and
invasion was dose-dependent. For each concentration of PL,
similar inhibition values were reached for adhesion and invasion
of NTHi. These results suggest that the observed reduction in
bacterial internalization relates to the inhibition of bacterial
adhesion to the cell membrane.
To test the possibility that surfactant MLVs would have a
direct bactericidal effect on NTHi that would lead to the observed
decreased C.F.U. in infection experiments, we analyzed bacterial
viability in the presence and absence of MLVs at the greatest
PL concentration assayed. Polymyxin B was used as a positive
control of bacterial killing. Bacterial viability was determined
by propidium iodide exclusion. Figure 2B shows that MLVs
from native or synthetic surfactant preparations did not have
bactericidal action against NTHi.
To test whether NTHi can stick to MLVs, so that surfactant
lipids might serve as a sink absorbing the bacteria, we analyzed
NTHi aggregation in the presence and absence of MLVs
prepared from the surfactant hydrophobic fraction (PL/SP-B/SP-
C). Figure 2C shows that MLVs significantly decreased bacterial
aggregation over time. These results indicate that surfactant
MLVs bind to bacteria, impairing bacterial self-aggregation and
bacterial attachment to epithelial cells.
Altogether, our results indicate that extracellular
surfactant membranes would function as biological barriers
that bind to bacteria and prevent bacterial adhesion to
the epithelium.
Endocytosed Surfactant Lipids Inhibited
NTHi Invasion by Blocking Bacterial
Uptake in Pneumocytes
With the aim of analyzing intracellular effect of endocytosed
surfactant vesicles on NTHi adhesion and invasion, mouse
FIGURE 4 | Endocytosis of surfactant lipids attenuates NTHi entry in pneumocytes. MLE-12 cells were incubated with or without SUVs composed of surfactant lipids
(250 µg PL/ml) for 24 h. Then cells were infected with otitis NTHi, and bacterial invasion assays were performed. Cells were then washed, fixed, and permeabilized
with 0.1% saponin. For confocal microscopy analysis, internalized bacteria were stained with an anti-NTHi antibody and Alexa Fluor 488-conjugated secondary
antibody. Late endosomes were stained with anti-LAMP1 antibody conjugated with phycoerytrin, and nuclei were stained with DAPI. (A) The graph shows the
percentage of internalized bacteria relative to cell associated individual bacteria. Mean ± SEM of two independent experiments are shown. Student’s t-test was used.
(B) Representative micrographs are shown.
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pneumocytes were preincubated with SUVs 24 h before infection.
Then, cells were washed, independently infected with the
two NTHi clinical strains, and both adhesion and invasion
experiments were performed. Results indicated that endocytosed
surfactant vesicles significantly inhibited otitis-NTHi invasion
but not bacterial adhesion to mouse MLE-12 (Figure 3A) and
human A549 (Supplementary Figure 2A) pneumocytes. Higher
concentrations of PL are needed to inhibit COPD NTHi strain
(Supplementary Figure 2B). This strain had a greater invasion
capacity, as long as the number of C.F.U. recovered in invasion
experiments was one order of magnitude greater than that of
the otitis NTHi strain (data not shown). These experiments
suggest that pneumocytes that endocytose small surfactant
vesicles, as part of the surfactant recycling cycle, show reduced
NTHi invasion.
Whenmouse pneumocytes were co-incubated with NTHi and
SUVs for just 30min, small PL vesicles also reduced bacterial
adhesion to the epithelium (Figure 3B), but the PL concentration
required for bacterial adhesion inhibition was greater for SUVs
than for MLVs (Figure 3A). Small PL vesicles bound to NTHi
decreasing NTHi self-aggregation at the highest concentration
tested (Supplementary Figure 2C). Importantly, co-incubation
of mouse pneumocytes with NTHi and SUVs for 2 h resulted
in a robust inhibition of bacterial invasion at very low PL
concentrations, likely due to SUV’s endocytosis (Figure 3B).
However, the effect of SUVs on NTHi invasion in coincubation
FIGURE 5 | SR-BI mediates endocytosis of small surfactant vesicles by pneumocytes. (A) MLE-12 cells were incubated in the presence or absence of SUVs (250 µg
PL/ml) for 2 h, then cells were harvested and stained with anti-SR-BI, anti-CD36 or their respective controls, rabbit IgG or mouse IgAκ, and appropriate Alexa Fluor
488-conjugated secondary antibodies. The mean fluorescence intensity (MFI) of SR-BI and CD36 was measured by flow cytometry, and background fluorescence
from IgG and IgAκ controls was subtracted. Data are presented as mean ± SEM of two independent experiments run in triplicate. Student’s t-test was used.
**p < 0.01, and ***p < 0.001 when compared with control cells in the absence of lipids. In (B,C), anti-SR-BI and anti-CD36 blocking antibodies or their respective
controls, rabbit IgG or mouse IgAκ, were added to MLE-12 cells for 30min. Then cells were incubated with DiIC18(3)-labeled SUVs (100µg/ml) for an additional
60min. (B) Cells were fixed, stained with Alexa Fluor 488-WGA (cell membranes) and DAPI (nuclei), and analyzed by confocal microscopy. (C) Cells were fixed and
analyzed by flow cytometry. A representative histogram is shown. The mean fluorescence intensity is represented as percentage of positive control, which is cells
incubated with DiIC18(3)-labeled SUVs in the absence of antibodies. Data are presented as mean ± SEM of three independent experiments run in triplicate. ANOVA
followed by the Bonferroni multiple-comparison test was used. ***p < 0.001 when compared with cells incubated with SUVs in the absence of antibodies.
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experiments was greater than that observed when SUVs were
previously endocytosed by epithelial cells (Figure 3A), suggesting
that the effect of SUVs on reducing NTHi aggregation and
bacterial adhesion might also influence bacterial invasion.
Once epithelial cells were infected by NTHi, post-infection
treatment with SUVs had no effect on the number of CFU
recovered in invasion experiments (Figure 3C). This suggests
that uptake of SUVs post-infection did not affect survival of
previously internalized bacteria.
To assess that endocytosed surfactant lipids inhibited
NTHi invasion by blocking bacterial uptake in pneumocytes,
we analyzed internalized fluorescent bacteria by confocal
microscopy (Figure 4). To this end, bacteria were stained
with an antibody against NTHi and Alexa-488-conjugated
secondary antibody, late endosomes were stained with a PE-
conjugated anti-LAMP1 antibody, and cell nuclei were stained
with DAPI. In absence of lipids, fluorescent NTHi bacteria
co-localized with late endosomes, as previously described (6).
However, when cells were preincubated with small surfactant
vesicles for 24 h prior to infection, a 70% reduction of
fluorescent bacteria was observed inside the cells. These results
indicate that endocytosed surfactant lipids inhibited NTHi entry
in pneumocytes.
FIGURE 6 | Blocking scavenger receptor SR-BI abrogates surfactant lipid
inhibition of NTHi invasion. Mouse pneumocytes were preincubated with or
without anti-SR-BI or control rabbit IgG antibodies for 30min, followed by 2 h
incubation with SUVs composed of a mixture of surfactant lipids (100 µg
PL/ml). Then, cells were infected with otitis NTHi, and invasion experiments
were performed. Bacterial invasion was quantified by colony counting, and
results were expressed as percentage of C.F.U. relative to cells infected in the
absence of lipids and antibodies. The percentages of C.F.U. obtained in cells
infected in the absence of lipids were not affected by the presence or absence
of antibodies (control IgG or anti-SR-BI). Mean ± SEM of two independent
experiments done in duplicate are shown. ANOVA followed by the Bonferroni
multiple-comparison test was used. *p < 0.05 and **p < 0.01 when compared
with infected pneumocytes in the absence of surfactant lipids and antibodies.
FIGURE 7 | Endocytosis of surfactant lipids inhibits signaling pathways
involved in NTHi internalization. (A) Mouse pneumocytes were preincubated
with SUVs of surfactant lipids (100 or 250 µg PL/ml) for 24 h. Then cells were
washed and infected with otitis NTHi for 45min. Cells were lysed, and p-Akt
and total Akt were analyzed by western blot. p-Akt was normalized to total
(Continued)
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FIGURE 7 | Akt, and data are shown as percentage of NTHi-induced Akt
phosphorylation in the absence of lipids. Mean ± SEM of three independent
experiments performed in triplicate are shown. ANOVA followed by Bonferroni
multiple-comparison test was used. ***p < 0.001 when compared with
untreated and uninfected cells. ◦◦ p < 0.01 and ◦◦◦p < 0.001 when compared
with infected pneumocytes in the absence of surfactant lipid vesicles.
(B) MLE-12 cells were preincubated with SUVs of surfactant lipids (250 µg PL
/ml) for 24 h. Then cells were infected with otitis NTHi for 2 h and activation of
the GTPase Rac1 was analyzed by pull-down and western blot. Rac1-GTP
and total Rac1 were quantified, and data are shown as percentage of
NTHi-induced Rac1 activation (fold increase) relative to uninfected cells in the
absence of lipids. Mean ± SEM of four independent experiments performed in
triplicate are shown. ANOVA followed by the Bonferroni multiple-comparison
test was used. *p < 0.05 when compared with untreated and uninfected cells.
◦p < 0.05 when compared with infected pneumocytes in the absence of
surfactant lipids.
Blocking Scavenger Receptor SR-BI
Abrogates Surfactant Lipid Inhibition of
NTHi Invasion
Although surfactant lipids may be endocytosed by type
II pneumocytes via clathrin-dependent and -independent
mechanisms (46), the receptors that mediate lipid vesicle
endocytosis by pneumocytes have not been entirely identified.
Scavenger receptors (SR) are involved in lipid uptake (47) and SR-
BI and SR-BII (CD36) interact with anionic phospholipids (48).
In addition, these receptors are expressed in airway epithelial
cells (49). The expression of SR-BI and CD36 receptors on the
surface of MLE-12 epithelial cells was examined in the presence
and absence of surfactant PL. We observed that the expression
of both SR-BI and CD36 was significantly reduced in response to
lipid vesicle internalization (Figure 5A).
To determine the effect of blocking antibodies of SR-BI
and CD36 receptors on the endocytosis of small surfactant
vesicles, alveolar epithelial cells were preincubated with blocking
antibodies or their respective immunoglobulin controls, and
endocytosis of DiIC18-fluorescent lipid vesicles was determined
by confocal microscopy (Figure 5B) and flow cytometry
(Figure 5C). We identified SR-BI as the receptor with a
prominent role in the endocytosis of surfactant lipids, since the
anti-SR-BI blocking antibody caused 70 % reduction of SUVs
endocytosis by mouse and human pneumocytes (Figure 5C and
Supplementary Figure 3). In contrast, anti-CD36 produced only
20 % PL endocytosis reduction by human cells, and it had
no effect on PL endocytosis by mouse cells (Figure 5C and
Supplementary Figure 3).
Next, we investigated whether the engulfment of surfactant
lipids by SR-BI might be critical for the attenuation of NTHi
invasion (Figure 6). To this end, MLE-12 cells were pre-
incubated in the presence or absence of anti-SR-BI blocking
antibody or its IgG control for 30min before incubating with
surfactant lipid vesicles for 2 h. After washing, cells were infected
with NTHi and bacterial invasion experiments were performed.
We found that, in the absence of lipids, anti-SR-BI antibody
did not have any effect on NTHi invasion, because the number
of bacteria internalized in the cells was similar to that of
control experiments without blocking SR-BI antibody or in
the presence of its IgG control (Figure 6). Importantly, in the
presence of small lipid vesicles, the blockade of SR-BI impeded
lipid-induced inhibition of NTHi invasion (Figure 6). Thus,
blocking the endocytosis of lipid vesicles increased pneumocyte
susceptibility to NTHi invasion. These results demonstrate that
SR-BI-mediated internalization of surfactant lipids is required
for lipid-dependent inhibition of NTHi invasion of alveolar
epithelial cells.
Endocytosis of Surfactant Lipids Inhibits
Signaling Pathways Involved in NTHi
Internalization
NTHi was shown to enter bronchial epithelial cells through
macropinocytosis (50). NTHi internalization seems to be
mediated by either direct bacterium binding to integrins or
indirect binding through extracellular matrix proteins (51, 52).
Integrin signaling leads to phosphorylation of focal adhesion
kinase (FAK), followed by activation of Rac1 GTPase and PI3K
to induce actin polymerization and membrane protrusion (52).
We previously showed that activation of both Rac1 and PI3K is
essential for NTHi entry in A549 epithelial cells (7).
To determine whether endocytosed surfactant vesicles
reduced bacterial entry into pneumocytes by blocking key
signaling pathways required for NTHi internalization, the
next step was to evaluate NTHi-induced PI3K-Akt and Rac1
activation in mouse and human pneumocytes preincubated
with or without surfactant lipid vesicles (Figure 7 and
Supplementary Figure 4). We found that NTHi infection
induced Akt phosphorylation (Figure 7A) and Rac1 GTPase
activation (Figure 7B) in mouse pneumocytes, as previously
described in human A549 cells (7). Endocytosed surfactant
lipid vesicles inhibited NTHi-induced Akt phosphorylation
in mouse (Figure 7A) and human (Supplementary Figure 4)
pneumocytes. Furthermore, endocytosed surfactant lipids
blocked NTHi-induced Rac1 activation (Figure 7B).
These results suggest that endocytosis of surfactant
phospholipid vesicles interferes with cytoskeletal reorganization
required for membrane protrusions that facilitate bacterial entry
in pneumocytes.
Surfactant Administration Protects From
NTHi Infection in vivo
Lastly, we wondered whether lung surfactant administration
could protect from NTHi infection in vivo. To test this
hypothesis, we infected CD1 mice intratracheally with a
clinical NTHi strain from otitis patients, and simultaneously
we instilled the hydrophobic fraction of native surfactant that
contains surfactant lipids and the hydrophobic proteins SP-
B and SP-C. Then, bacterial burden was assessed in whole
lung tissue and BAL after 6, 12, and 24 h post infection.
Figure 8 shows that administration of exogenous lung surfactant
significantly diminished bacterial load in lung tissue and BAL
of NTHi infected mice 12–24 h after surfactant administration,
supporting the notion that the lipid component of lung
surfactant protects against NTHi infection. Analyses of cell
types in BAL from infected mice treated with or without
surfactant revealed that recruited cells consisted predominantly
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FIGURE 8 | Surfactant treatment accelerated bacterial clearance in lung tissue and BAL of NTHi infected mice. Mice were intratracheally infected with otitis NTHi
strain (4 × 107 C.F.U./mouse), and the hydrophobic fraction of native pulmonary surfactant (25mg PL/kg body weigh) was simultaneously instilled into the lungs (or
the same volume of PBS in the untreated infected group). Mice were euthanized at 6, 12, or 24 h postinfection. Lungs were harvested, weighed, and homogenized
(left lung) or used for BAL extraction (right lung) (n = 5 mice each infected group; n = 3 mice each uninfected group). (A) The numbers of viable bacteria in lung
homogenates and BAL were assessed by colony counting and expressed as log10 (C.F.U./mouse). Results are mean ± SEM. ANOVA followed by Bonferroni
multiple-comparison test was used. **p < 0.01, and ***p < 0.001 when compared with untreated infected groups. (B) Percentage of alveolar macrophage and
neutrophil counts in BAL. Results are mean ± SEM. ANOVA followed by the Bonferroni multiple-comparison test was used. *p < 0.05, **p < 0.01, and ***p < 0.001
when compared with the corresponding uninfected group.
of neutrophils (Figure 8). Neutrophil recruitment was similar in
infected mice treated with surfactant compared with untreated
infected animals. Control experiments indicate that neutrophil
recruitment did not significantly increase in uninfected mice
treated with surfactant compared with untreated uninfectedmice
(Figure 8). These results suggest that the accelerated clearance
of NTHi in mice treated with surfactant was not associated with
increased neutrophil infiltration at 6, 12, and 24 h post-infection
in surfactant-treated mice compared with untreated mice.
DISCUSSION
Lung surfactant has two essential functions: keeping the
alveolus open and host defense. These functions are inseparably
coordinated and depend on the complexity of surfactant’s
components (19). Whereas surfactant proteins SP-A and SP-
D have a clear role in lung defense, attention to surfactant
lipids and hydrophobic surfactant proteins has been focused on
surface tension properties. Whether surfactant lipids participate
in the control of infection by inhaled pathogens remains
mostly unaddressed.
In the present study, we demonstrated that the lipid
component of pulmonary surfactant interferes with
pathogen-host interaction between NTHi and pneumocytes
through two different mechanisms. On the one hand,
large extracellular surfactant vesicles bind to NTHi and
function as biological barriers to reduce the number of
bacteria adhered and internalized in alveolar epithelial cells.
On the other hand, small surfactant vesicles were rapidly
endocytosed by pneumocytes, mainly via the scavenger
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receptor SR-BI that mediates clathrin- and dynamin-
independent endocytosis (53). The endocytosed surfactant
lipids inhibited NTHi invasion by blocking bacterial uptake
in pneumocytes.
Macropinocytosis is exploited by several intracellular
pathogens as a means of entry into cells (54). This process
is responsible for the uptake of large particles, >0.5µm in
diameter. The NTHi entry into pneumocytes requires direct
or indirect bacterial binding to integrins, which initiate
the activation of the Src/GEF Vav2/Rac1 GTPase/Pak1
signaling axis for polymerization of microtubules and cell
ruﬄing (6, 7). These cytoskeletal remodeling proteins are
bound to phosphatidylinositol (PtdIns)(4, 5)P2, which
is enriched at the macropinocytic site in early stages of
macropinosome development (54–56). Interestingly, PtdIns(4,
5)P2 disappearance is critical for macropinosome formation.
At this stage, PtdIns(3,4,5)P3 is formed by PI3K activity.
PtdIns(3,4,5)P3 is essential for cup closure (54–56). By recruiting
adaptors, GEFs and GAPs that contain PtdIns(3,4,5)P3-
interacting PH domains, the cell is able to dictate the activity
of Rho family GTPases that direct the polymerization of actin
required for macropinosome closure. Consistent with this, we
previously found that inhibition of PI3K or Rac1 activation
abrogates NTHi internalization (6, 7).
In this study, we show that NTHi-induced Rac1 GTPase
activation and Akt phosphorylation by pneumocytes was
inhibited by endocytosed surfactant lipids. Therefore, small
surfactant lipid vesicles, once endocytosed, block intracellular
signaling pathways that are required for NTHi entry into
pneumocytes. The mechanism by which endocytosed lipid
vesicles show such inhibitory effects is unknown. Given that
clathrin-independent endocytosis of small particles also requires
PtdIns(4,5)P2 for membrane curvature and invagination (55, 56)
as well as Src, Rac1, or ARF signaling proteins that bind to
PtdIns(4,5)P2, it is possible that endocytosis of lipid vesicles
could shuttle PtdIns(4,5)P2 and associated proteins from the
plasma membrane into internal membranes. The sequestration
of PtdIns(4,5)P2 and Src, Rac1, or ARF could inhibit bacterial
entry since depletion of PtdIns(4,5)P2 in the macropinocytic site
reduces the macropinocytic or phagocytic efficiency (57).
To assess the beneficial role of lung surfactant lipids during
NTHi infection, we performed in vivo experiments treating
NTHi-infected mice with the hydrophobic fraction of native
surfactant isolated from rat lungs. We found that this surfactant
fraction, composed of PL, SP-B, and SP-C, was able to bind
to NTHi, which led to a significant reduction of NTHi
capability to self-aggregate. NTHi aggregation is responsible for
microcolony formation on the epithelial surfaces, facilitating
bacterial colonization of the airways (58). Administration of
the hydrophobic fraction of native surfactant to NTHi infected
mice significantly accelerated bacterial clearance in lung tissue
and BAL. Surfactant treatment did not significantly affect
early neutrophil recruitment in infected mice, suggesting that
surfactant vesicles are directly involved in preventing bacterial
adhesion to the epithelium and facilitating the actions of
airway macrophages, neutrophils, antimicrobial proteins, and
mucociliary clearance in promoting bacterial clearance.
Surfactant phospholipid concentration has been reported
to decrease in COPD and idiopathic pulmonary fibrosis (30,
59). Smokers have reduced surfactant phospholipid levels,
as well as impaired biophysical activity (30, 31). In asthma
or pneumonia, reduced levels of phosphatidylcholine and
changes in phospholipid composition have also been found
(30). Surfactant lipids are also significantly altered in the aged
lung in both mice and humans (60). In addition, pathological
conditions, such as previous infection with rhinovirus, can
reduce the inflammatory response and cause delay in NTHi
clearance (61). Thus, in a context of immune dysregulation, the
protective effect of pulmonary surfactant on NTHi respiratory
infection may be more necessary. Therapeutic interventions
with the hydrophobic fraction of surfactant might be of
potential benefit in respiratory diseases with NTHi infection
because exogenous surfactant protects against NTHi and
improves lung biophysical function. In addition, the use of
small surfactant-like vesicles as vehicles for inhaled drug
administration may have further added value. This lipid-
based host-directed strategy would offer novel prophylactic or
therapeutic options against chronic, recurrent, or drug-resistant
respiratory infections.
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